Wolverine Trading
ATOS icon

Wolverine Trading’s Atossa Therapeutics ATOS Stock Holding History

Wolverine Trading’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$23.8K Buy
+1,820
New +$22.5K ﹤0.01% 5523
2025
Q2 		– Sell
-1,987
Closed -$20.7K – 4705
2025
Q1 		$20.7K Buy
1,987
+727
+58% +$8.83K ﹤0.01% 4558
2024
Q4 		$18.4K Sell
1,260
-1,240
-50% -$24.2K ﹤0.01% 5116
2024
Q3 		$56.6K Sell
2,500
-213
-8% -$4.3K ﹤0.01% 4514
2024
Q2 		$48.4K Buy
+2,713
New +$60K ﹤0.01% 4223
2023
Q4 		– Sell
-3,727
Closed -$41.2K – 4476
2023
Q3 		$41.2K Buy
3,727
+54
+1% +$783 ﹤0.01% 4218
2023
Q2 		$70.5K Buy
3,673
+2,566
+232% +$31.1K ﹤0.01% 3867
2023
Q1 		$12K Sell
1,107
-3,780
-77% -$42.2K ﹤0.01% 4062
2022
Q4 		$39K Buy
+4,887
New +$56.1K ﹤0.01% 3625
2022
Q1 		– Sell
-12,733
Closed -$317K – 5370
2021
Q4 		$317K Buy
+12,733
New +$466K ﹤0.01% 4069
2021
Q3 		– Sell
-22,847
Closed -$2.47M – 6228
2021
Q2 		$2.47M Buy
+22,847
New +$1.21M ﹤0.01% 1769

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wolverine Trading's ATOS Position: Q3 2025 in Review

Wolverine Trading reduced its Atossa Therapeutics (ATOS) stake by 2.2% in Q3 2025, selling an estimated $346 and leaving 1,223 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #5549.

Wolverine Trading first reported a position in ATOS in Q2 2023 and has held it in 7 quarters since. The position peaked at $88.1K in Q1 2024. 66 funds tracked by Wall St. Rank hold ATOS as of Q3 2025.

  • Wolverine Trading held 1,223 shares of Atossa Therapeutics worth $16K as of Q3 2025.
  • Wolverine Trading sold 28 Atossa Therapeutics shares in Q3 2025, an estimated $346.
  • Atossa Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5549 holding.
  • Wolverine Trading first reported a position in Atossa Therapeutics in Q2 2023 and has held it in 7 quarters since.
  • Wolverine Trading's Atossa Therapeutics position peaked at $88.1K in Q1 2024.
  • 66 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.